← Back to Analyst Consensus 
DYN Buy
Dyne Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 21
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 3 reiterations from 3 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 30, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Sep 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Sep 29, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Sep 9, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Sep 9, 2026 | JP Morgan | downgrade | Neutral → Underweight | — | 54% |
| Sep 9, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Sep 9, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Jul 31, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jul 30, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 23, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| Jun 26, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| May 15, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| May 13, 2026 | Bernstein | maintain | Market Perform → Market Perform | — | 52% |
| Mar 9, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Mar 3, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $47 | 54% |
| Mar 3, 2026 | Chardan Capital | maintain | Buy → Buy | $38 | 47% |
| Mar 3, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $50 | 44% |
| Jan 20, 2026 | JP Morgan | maintain | Neutral → Neutral | $16 | 54% |
| Dec 15, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $36 | 58% |
| Dec 11, 2025 | Stifel | maintain | Buy → Buy | $39 | 53% |
| Dec 10, 2025 | Oppenheimer | upgrade | Perform → Outperform | $40 | 52% |
| Dec 9, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $50 | 54% |
| Dec 9, 2025 | Chardan Capital | maintain | Buy → Buy | $38 | 47% |
| Dec 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $60 | 44% |
| Nov 14, 2025 | JP Morgan | maintain | Neutral → Neutral | $17 | 54% |
| Nov 12, 2025 | Oppenheimer | maintain | Perform → Perform | $11 | 52% |
| Nov 6, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $46 | 44% |
| Nov 6, 2025 | RBC Capital | maintain | Outperform → Outperform | $30 | 55% |
| Oct 10, 2025 | Oppenheimer | downgrade | Outperform → Perform | $13 | 52% |
| Aug 25, 2025 | Raymond James | upgrade | Outperform → Strong Buy | $35 | 54% |
| Aug 6, 2025 | Oppenheimer | maintain | Outperform → Outperform | $13 | 52% |
| Jul 31, 2025 | Stifel | maintain | Buy → Buy | $36 | 53% |
| Jul 29, 2025 | RBC Capital | maintain | Outperform → Outperform | $23 | 55% |
| Jul 29, 2025 | Raymond James | reiterate | Outperform → Outperform | $31 | 54% |
| Jul 29, 2025 | Chardan Capital | maintain | Buy → Buy | $38 | 47% |
| Jul 15, 2025 | JP Morgan | maintain | Neutral → Neutral | $9 | 54% |
| Jun 26, 2025 | Jones Trading | initiate | — → Buy | $30 | 50% |
| Jun 18, 2025 | Guggenheim | reiterate | Buy → Buy | $50 | 52% |
| Jun 18, 2025 | Baird | maintain | Outperform → Outperform | $32 | 55% |
| Jun 17, 2025 | Chardan Capital | maintain | Buy → Buy | $50 | 47% |
| May 9, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $38 | 44% |
| May 9, 2025 | Chardan Capital | maintain | Buy → Buy | $50 | 47% |
| Mar 21, 2025 | JP Morgan | maintain | Neutral → Neutral | $17 | 54% |
| Mar 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $46 | 44% |
| Mar 17, 2025 | Chardan Capital | maintain | Buy → Buy | $50 | 47% |
| Mar 12, 2025 | BMO Capital | initiate | — → Outperform | $50 | 53% |
| Mar 7, 2025 | Scotiabank | initiate | — → Sector Outperform | $50 | 55% |
| Feb 28, 2025 | Chardan Capital | maintain | Buy → Buy | $50 | 47% |
| Feb 28, 2025 | Piper Sandler | maintain | Overweight → Overweight | $48 | 54% |
| Feb 28, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $46 | 44% |
Price Target Trend
Jun 12, 2026 Latest: $35.73 Oct 25, 2026
EPS Estimates
0q $-0.89
Lo: $-1.09 Hi: $-0.72
14 analysts ▲1
+1y $-3.34
Lo: $-4.53 Hi: $-2.79
13 analysts +1q $-0.89
Lo: $-1.11 Hi: $-0.36
14 analysts 0y $-3.55
Lo: $-3.94 Hi: $-2.94
15 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days